Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA lump felt in the neck during Mounjaro treatment is something to take seriously and check with a doctor, but it is not automatically a sign of something dangerous. Most people who notice neck swelling on tirzepatide have a benign explanation — swollen lymph nodes from a minor illness are by far the most common cause. That said, one specific concern associated with GLP-1 receptor agonists is medullary thyroid carcinoma (MTC), and it is precisely why a personal or family history of that condition rules out treatment with Mounjaro altogether. These are prescription-only medicines, and every person who starts them has already been assessed by a GPhC-registered Independent Prescriber who weighs up exactly these contraindications before issuing a prescription.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Social media has amplified the idea that tirzepatide routinely produces neck lumps, and the reality is more specific and more reassuring than that framing suggests. Mounjaro is not associated with lymph node swelling or general neck lumps as a recognised side effect. The neck-related concern in the prescribing guidance centres on one particular condition (medullary thyroid carcinoma) and it arises from a cautionary finding in rodent studies, not from a pattern of neck lumps in human patients. Rodents given GLP-1 receptor agonists at high doses developed thyroid C-cell tumours; the biological pathway for this does not translate cleanly to humans, and no increased MTC signal has emerged from the large tirzepatide clinical programme involving thousands of adults. The NHS tirzepatide medicines page lists the relevant cautions clearly, and MTC is addressed as a contraindication rather than a common side effect. What that means practically: if you have already been prescribed Mounjaro, your prescriber has already confirmed you do not have a history of MTC or Multiple Endocrine Neoplasia type 2 (MEN2). A lump appearing now is unlikely to be treatment-caused. It still needs checking, but the starting assumption is not alarm.
Neck lumps are extremely common in the general population and overwhelmingly benign. Lymph nodes are scattered throughout the neck and swell in response to infection, a cold, sore throat, ear infection or even a small skin wound nearby can produce a visible or palpable lump that resolves within a couple of weeks. If you started Mounjaro recently and noticed the lump around the same time, the timing may simply be coincidental. The treatment can cause some people to feel run-down during dose increases, which might slightly increase susceptibility to minor infections that then trigger node swelling. Muscle tension in the neck, benign thyroid cysts and sebaceous cysts are other common culprits. Some people starting tirzepatide also experience a sore, stiff neck related to how they carry the pen or from injection-site posture, and exploring that discomfort with their hands can surface a lymph node they had simply never noticed before. None of this means you should dismiss a new lump. A lump that persists beyond three weeks, grows, is hard or immobile, or comes with hoarseness, difficulty swallowing or unexplained weight loss beyond what you would expect from treatment deserves prompt medical attention. Report it to your GP or, if your prescription came through a private clinic, to your prescriber directly via their aftercare line.
Tirzepatide's prescribing information carries a contraindication for anyone with a personal or family history of medullary thyroid carcinoma, and for anyone with MEN2, a genetic syndrome that raises MTC risk substantially. This is not a side-effect warning about something Mounjaro causes in normal patients; it is a rule that excludes people who already carry a heightened thyroid risk from using the medicine at all. You can read about how tirzepatide works and its full eligibility criteria in more detail, but the short version is that the contraindication exists as a precaution based on animal data, and the prescriber's job at the consultation stage is to screen for exactly this history. If you are currently taking Mounjaro, that screening has been done. The MHRA monitors tirzepatide closely under its Black Triangle status, meaning any unexpected safety signal in real-world use gets captured rapidly. So far, no emerging MTC pattern in humans has been reported. If you are worried about your thyroid specifically (perhaps because you have noticed something unusual near the front of your neck rather than to the side) a GP can arrange blood tests and, if needed, an ultrasound. That is the right next step, not stopping treatment abruptly without advice.
A lump noticed on a Monday morning that has been there since the weekend cold is unlikely to need emergency action, but it does need logging. Contact your prescriber or GP within a few days if the lump is new and you cannot explain it; contact them the same day if it is growing quickly, tender to the touch in a way that is worsening, or accompanied by any of the red-flag symptoms listed above. At nume, the aftercare team is available seven days a week precisely for questions like this, you do not need to wait until a scheduled repeat review to raise a concern. You can reach us via the contact page any day of the week. Separately, it is worth knowing that related symptoms such as a sensation of a lump in the throat or neck pain can each have their own distinct causes on tirzepatide, those are covered on their own pages. If you are still weighing up whether Mounjaro is right for you and a neck history is part of that picture, a free consultation with our prescribers is the appropriate starting point: no rushing, no assumptions, just a thorough clinical review. Understanding what Mounjaro involves end-to-end can also help you ask better questions at that consultation. Cost is sometimes a factor in whether people seek advice, you can read an honest overview on our Mounjaro UK cost page if that is relevant to your decision.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.